Ann Dermatol.  2019 Jun;31(3):347-348. 10.5021/ad.2019.31.3.347.

Alitretinoin Treatment for Gefitinib-Induced Paronychia

• Lee SY
• Kim JW
• Yu DS
• Lee YB

• KMID: 2444873
• DOI: http://doi.org/10.5021/ad.2019.31.3.347

Abstract

No abstract available.

MeSH Terms

Paronychia*

Figure

• 

  Fig. 1 The patient showed substantial improvement of hand eczema, paronychia and onychodystrophy after six months of treatment.

Reference

1. Agero AL, Dusza SW, Benvenuto-Andrade C, Busam KJ, Myskowski P, Halpern AC. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol. 2006; 55:657–670.

2. Alsenaid A, Eder I, Ruzicka T, Braun-Falco M, Wolf R. Successful treatment of nail lichen planus with alitretinoin: report of 2 cases and review of the literature. Dermatology. 2014; 229:293–296.

3. Iorizzo M. Nail lichen planus-a possible new indication for oral alitretinoin. J Eur Acad Dermatol Venereol. 2016; 30:509–510.

4. Milanesi N, D'Erme AM, Gola M. Nail improvement during alitretinoin treatment: three case reports and review of the literature. Clin Exp Dermatol. 2015; 40:533–536.

5. Figueiras Dde A, Ramos TB, Marinho AK, Bezerra MS, Cauas RC. Paronychia and granulation tissue formation during treatment with isotretinoin. An Bras Dermatol. 2016; 91:223–225.